{
    "nctId": "NCT04736186",
    "briefTitle": "Prevention and Treatment of Pyrrolitinib-associated Diarrhea",
    "officialTitle": "Prevention and Treatment of Pyrrolitinib-associated Diarrhea: a Prospective, Multicenter, Open-label Clinical Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 470,
    "primaryOutcomeMeasure": "time from the first day of treatment until diarrhea returns to level 0 or baseline during the first day of treatment to the 22nd day of treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. One of the following two situations:\n\n   A) Plan to take pyrrolitinib for \u226521 days; B) Third-degree diarrhea or second-degree diarrhea with complications after taking pyrrolitinib at present, plan to take pyrrolitinib for \u226521 days;\n2. Age \u226518 years;\n3. ECOG PS 0-2;\n4. Life expectancy \u22656 months;\n5. Participate in this study voluntarily, sign informed consent, have good compliance and are willing to cooperate with the follow-up.\n\nExclusion Criteria:\n\n1. May be allergic to pyrrolitinib or excipients;\n2. There are many factors affecting the absorption of oral drugs, such as inability to swallow, nausea and vomiting;\n3. Patients with biliary obstruction;\n4. Participate in other diarrhea-related clinical trials;\n5. Pregnant and lactating women, fertile women who tested positive in the baseline pregnancy test, or women of childbearing age who were unwilling to use effective contraception during the whole trial period;\n6. Concomitant diseases (including but not limited to severe hypertension beyond the control of drugs, severe diabetes, etc.) that, according to the judgment of the researcher, seriously endanger the safety of the patient or affect the completion of the study; The investigator concluded that the patient was not eligible for any of the other conditions in the study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}